查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609601

质体DNA製造市场规模、份额、趋势分析报告：依疾病、等级、应用、发展阶段、地区、细分市场预测，2025-2030年

Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Disease (Cancer, Infectious Diseases), By Grade (R&D, GMP), By Application, By Development Phase, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

质体DNA 製造市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球质体DNA製造市场规模将达67亿美元，2025年至2030年复合年增长率为21.44%。

慢性病盛行率的上升加上质体DNA在医疗保健产业的广泛应用预计将推动该产业的成长。质体DNA 可直接用于治疗应用，例如疫苗抗原的生产和基因治疗。此外，它还可用于各种研究目的，例如基因克隆和基因图谱。选择基因治疗的患者数量不断增加预计将在未来几年推动行业成长。

根据 ClinicalTrials.gov 的数据，全球管道计画（I 期至 III 期试验）的细胞和基因疗法数量从 2018 年的 289 种增加到 2022 年的 327 种。此外，美国FDA 持续透过与产品製造相关的多项政策支持先进治疗领域的创新。随着细胞和基因治疗产品的激增，该产业可能需要大规模生产质体DNA。 COVID-19 大流行预计将对行业成长产生积极影响。例如，2021 年 9 月，印度核准了第一个 COVID-19 DNA 疫苗。这是世界上第一个与 DBT-BIRAC 合作生产的世界上第一个 COVID-19 DNA 疫苗，作为 Mission COVID Suraksha 的一部分。

印度的 ZyCoV-D 疫苗接种中使用了环状 DNA，以预防 COVID-19 感染。此外，全球产业的主要企业正在采取各种策略措施来增加其在市场上的影响力，这也有望推动成长。例如，2022年6月，Biosina宣布在新的专用GMP套件中扩大质体DNA生产，以提供CDMO服务。该套件具有高达 300L 的一次性发酵容量和适当规模的下游加工机械。

质体DNA 製造市场报告亮点

  • MP 级质体DNA 製造在 2024 年以 86.29% 的份额占据市场主导地位，预计在预测期内将以最快的复合年增长率增长。
  • 2024年，临床治疗领域占最大市场占有率，达54.6%。质体DNA 目前在基因疫苗和基因治疗的临床研究应用中变得越来越重要。
  • 细胞和基因治疗领域占最大市场占有率，2024年为54.4%。如此高的份额是由于基因疗法广泛应用于治疗遗传性疾病。
  • 预计2024年癌症领域将占最大市场占有率，达40.0%，2025年至2030年复合年增长率最快。
  • 北美质体DNA製造市场占最大销售份额，2024年占全球市场的43.43%。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场趋势及展望
  • 市场动态
    • 越来越多的患者选择基因治疗
    • 基因治疗的强大管道
    • 市场竞争激烈，市场参与企业采取不同的策略
    • 各种医学治疗中对质体DNA 的需求增加
  • 市场限制因素分析
    • 与基因治疗相关的监管、科学和伦理挑战
  • 营商环境分析
    • PESTEL分析
    • 波特五力分析
    • COVID-19 影响分析

第四章 业务等级分析

  • 细分仪表板
  • 全球质体DNA製造市场波动分析
  • 2018-2030年全球质体DNA製造市场规模及趋势分析
  • 研发级
    • 病毒载体的开发
    • mRNA发育
    • 抗体开发
    • DNA疫苗开发
    • 其他的
  • GMP级

第五章 按发展阶段分類的业务分析

  • 细分仪表板
  • 全球质体DNA製造市场波动分析
  • 2018-2030年全球质体DNA製造市场规模及趋势分析
  • 临床前治疗
  • 临床治疗
  • 已上市治疗药物

第六章 依应用分类的业务分析

  • 细分仪表板
  • 全球质体DNA製造市场波动分析
  • 2018-2030年全球质体DNA製造市场规模及趋势分析
  • DNA疫苗
  • 细胞/基因治疗
  • 免疫疗法
  • 其他的

第七章 依疾病分类的商业分析

  • 细分仪表板
  • 全球质体DNA製造市场波动分析
  • 2018-2030年全球质体DNA製造市场规模及趋势分析
  • 感染疾病
  • 癌症
  • 遗传疾病
  • 其他的

第八章 依等级、发育阶段、病害和用途进行区域估算和趋势分析

  • 区域市场仪表板
  • 2024年及2030年全球质体DNA製造市场占有率（按地区）
  • 北美洲
    • 北美质体DNA 製造市场，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲质体DNA 製造市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区质体DNA 製造市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲质体DNA 製造市场，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 中东和非洲质体DNA 製造市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 参与企业
  • 2024 年企业市场分析
  • 参与企业概况
    • Charles River Laboratories
    • Danaher
    • VGXI, Inc.
    • Kaneka Corp.
    • Lonza
    • Nature Technology
    • Cell and Gene Therapy Catapult
    • Eurofins Genomics
    • Luminous BioSciences, LLC
    • Akron Biotech
Product Code: GVR-4-68039-977-1

Plasmid DNA Manufacturing Market Growth & Trends:

The global plasmid DNA manufacturing market size is expected to reach USD 6.70 billion by 2030, expanding at a CAGR of 21.44% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases, combined with the wide application scope of plasmid DNA in the healthcare industry is expected to drive the industry growth. Plasmid DNA can be used directly for therapeutic applications, such as the production of vaccine antigens or gene therapy. Moreover, it can be utilized for various research purposes, such as gene cloning, gene mapping, etc. The rising number of patients choosing gene therapy is expected to drive industry growth in the coming years.

According to clinicaltrials.gov, the number of cell & gene therapies across global pipeline programs (Phase I to Phase III trials) increased from 289 in 2018 to 327 in 2022. Furthermore, the U.S. FDA provides constant support for innovations in the advanced therapy arena via several policies concerning product manufacturing. With increased cell and gene therapy products, the industry will see an increased need for manufacturing plasmid DNA on a larger scale. The COVID-19 pandemic is anticipated to positively impact industry growth. For instance, in September 2021, India approved the first COVID-19 DNA vaccine. It is the world's first COVID-19 DNA vaccine manufactured in partnership with DBT-BIRAC as part of Mission COVID Suraksha.

Circular DNA is used in India's ZyCoV-D vaccination to protect against COVID-19 infection. Furthermore, key entities in the global industry are undertaking various strategic initiatives to strengthen their market presence, which is also expected to propel growth. For instance, in June 2022, BioCina announced the expansion of the production of plasmid DNA in a new dedicated GMP suite to its offering of CDMO services. The suite has a single-use fermentation capacity of up to 300 L and appropriately scaled downstream processing machinery.

Plasmid DNA Manufacturing Market Report Highlights:

  • MP-grade plasmid DNA manufacturing dominated the market in 2024 with a share of 86.29% and is expected to grow at the fastest CAGR over the forecast period.
  • The clinical therapeutics segment held the largest market share of 54.6% in 2024. Plasmid DNA is currently increasing in importance for clinical research applications in genetic vaccination and gene therapy.
  • The cell & gene therapy segment held the largest market share of 54.4% in 2024. This high share can be attributed to the fact that gene therapy is broadly applied in the treatment of several inherited and genetic diseases.
  • The cancer segment held the largest market share of 40.0% in 2024 and is expected to witness the fastest CAGR from 2025 to 2030.
  • The North America Plasmid DNA manufacturing market held the largest revenue share of 43.43% of the global market in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Grade
    • 1.2.2. Development Phase
    • 1.2.3. Application
    • 1.2.4. Disease
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
    • 1.9.1. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Increasing number of patients opting for gene therapy
    • 3.3.2. Robust pipeline for gene therapies
    • 3.3.3. Highly competitive market and various strategies undertaken by market players
    • 3.3.4. Increasing demand for plasmid DNA in various medical therapies
  • 3.4. Market Restraint Analysis
    • 3.4.1. Regulatory, Scientific, And Ethical Challenges Associated With Gene Therapy
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Grade Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Plasmid DNA Manufacturing Market Movement Analysis
  • 4.3. Global Plasmid DNA Manufacturing Market Size & Trend Analysis, by Grade, 2018 to 2030 (USD Million)
  • 4.4. R&D Grade
    • 4.4.1. R&D Grade Market, 2018 - 2030 (USD Million)
    • 4.4.2. Viral Vector Development
      • 4.4.2.1. Viral Vector Development Market, 2018 - 2030 (USD Million)
      • 4.4.2.2. AAV
        • 4.4.2.2.1. AAV Market, 2018 - 2030 (USD Million)
      • 4.4.2.3. Lentivirus
        • 4.4.2.3.1. Lentivirus Market, 2018 - 2030 (USD Million)
      • 4.4.2.4. Adenovirus
        • 4.4.2.4.1. Adenovirus Market, 2018 - 2030 (USD Million)
      • 4.4.2.5. Retrovirus
        • 4.4.2.5.1. Retrovirus Market, 2018 - 2030 (USD Million)
      • 4.4.2.6. Others
        • 4.4.2.6.1. Others Market, 2018 - 2030 (USD Million)
    • 4.4.3. mRNA Development
      • 4.4.3.1. mRNA Development Market, 2018 - 2030 (USD Million)
    • 4.4.4. Antibody Development
      • 4.4.4.1. Antibody Development Market, 2018 - 2030 (USD Million)
    • 4.4.5. DNA Vaccine Development
      • 4.4.5.1. DNA Vaccine Development Market, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. GMP Grade
    • 4.5.1. GMP Grade Market, 2018 - 2030 (USD Million)

Chapter 5. Development Phase Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Plasmid DNA Manufacturing Market Movement Analysis
  • 5.3. Global Plasmid DNA Manufacturing Market Size & Trend Analysis, by Development Phase, 2018 to 2030 (USD Million)
  • 5.4. Pre-Clinical Therapeutics
    • 5.4.1. Pre-Clinical Therapeutics Market, 2018 - 2030 (USD Million)
  • 5.5. Clinical Therapeutics
    • 5.5.1. Clinical Therapeutics Market, 2018 - 2030 (USD Million)
  • 5.6. Marketed Therapeutics
    • 5.6.1. Marketed Therapeutics Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Plasmid DNA Manufacturing Market Movement Analysis
  • 6.3. Global Plasmid DNA Manufacturing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. DNA Vaccines
    • 6.4.1. DNA Vaccines Market, 2018 - 2030 (USD Million)
  • 6.5. Cell & Gene Therapy
    • 6.5.1. Cell & Gene Therapy Market, 2018 - 2030 (USD Million)
  • 6.6. Immunotherapy
    • 6.6.1. Immunotherapy Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Disease Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Plasmid DNA Manufacturing Market Movement Analysis
  • 7.3. Global Plasmid DNA Manufacturing Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
  • 7.4. Infectious Disease
    • 7.4.1. Infectious Disease Market, 2018 - 2030 (USD Million)
  • 7.5. Cancer
    • 7.5.1. Cancer Market, 2018 - 2030 (USD Million)
  • 7.6. Genetic Disorder
    • 7.6.1. Genetic Disorder Market, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Estimates & Trend Analysis by Grade, Development Phase, Disease, & Application

  • 8.1. Regional Market Dashboard
  • 8.2. Global Plasmid DNA Manufacturing Market Share By Region, 2024 & 2030
  • 8.3. North America
    • 8.3.1. North America Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Target Disease Prevalence
      • 8.3.2.5. U.S. Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Target Disease Prevalence
      • 8.3.3.5. Canada Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Target Disease Prevalence
      • 8.3.4.5. Mexico Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Target Disease Prevalence
      • 8.4.2.5. Germany Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Target Disease Prevalence
      • 8.4.3.5. UK Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Target Disease Prevalence
      • 8.4.4.5. France Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Target Disease Prevalence
      • 8.4.5.5. Italy Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Target Disease Prevalence
      • 8.4.6.5. Spain Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Target Disease Prevalence
      • 8.4.7.5. Denmark Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Target Disease Prevalence
      • 8.4.8.5. Sweden Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Target Disease Prevalence
      • 8.4.9.5. Norway Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Target Disease Prevalence
      • 8.5.2.5. Japan Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Target Disease Prevalence
      • 8.5.3.5. China Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Target Disease Prevalence
      • 8.5.4.5. India Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Target Disease Prevalence
      • 8.5.5.5. South Korea Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Target Disease Prevalence
      • 8.5.6.5. Australia Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Target Disease Prevalence
      • 8.5.7.5. Thailand Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Target Disease Prevalence
      • 8.6.2.5. Brazil Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Target Disease Prevalence
      • 8.6.3.5. Argentina Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Target Disease Prevalence
      • 8.7.2.5. South Africa Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Target Disease Prevalence
      • 8.7.3.5. Saudi Arabia Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Target Disease Prevalence
      • 8.7.4.5. UAE Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Target Disease Prevalence
      • 8.7.5.5. Kuwait Plasmid DNA Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Company Market Position Analysis, 2024
  • 9.3. Participant's Overview
    • 9.3.1. Charles River Laboratories
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Danaher
      • 9.3.2.1. Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. VGXI, Inc.
      • 9.3.3.1. Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Kaneka Corp.
      • 9.3.4.1. Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Lonza
      • 9.3.5.1. Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Nature Technology
      • 9.3.6.1. Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Cell and Gene Therapy Catapult
      • 9.3.7.1. Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Eurofins Genomics
      • 9.3.8.1. Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Luminous BioSciences, LLC
      • 9.3.9.1. Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Akron Biotech
      • 9.3.10.1. Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 4 Global Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 5 Global Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 6 Global Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 7 North America Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 8 North America Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 9 North America Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 10 North America Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 11 North America Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD million)
  • Table 12 U.S. Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 13 U.S. Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 14 U.S. Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 15 U.S. Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 16 Canada Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 17 Canada Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 18 Canada Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 19 Canada Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 20 Mexico Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 21 Mexico Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 22 Mexico Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 23 Mexico Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 24 Europe Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 25 Europe Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 26 Europe Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 27 Europe Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 28 Europe Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD million)
  • Table 29 U.K. Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 30 U.K. Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 31 U.K. Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 32 U.K. Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 33 Germany Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 34 Germany Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 35 Germany Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 36 Germany Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 37 France Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 38 France Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 39 France Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 40 France Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 41 Italy Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 42 Italy Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 43 Italy Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 44 Italy Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 45 Spain Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 46 Spain Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 47 Spain Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 48 Spain Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 49 Denmark Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 50 Denmark Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 51 Denmark Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 52 Denmark Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 53 Sweden Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 54 Sweden Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 55 Sweden Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 56 Sweden Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 57 Norway Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 58 Norway Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 59 Norway Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 60 Norway Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 61 Asia Pacific Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 62 Asia Pacific Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 63 Asia Pacific Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 64 Asia Pacific Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 65 Asia Pacific Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD million)
  • Table 66 China Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 67 China Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 68 China Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 69 China Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 70 Japan Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 71 Japan Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 72 Japan Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 73 Japan Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 74 India Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 75 India Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 76 India Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 77 India Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 78 South Korea Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 79 South Korea Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 80 South Korea Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 81 South Korea Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 82 Australia Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 83 Australia Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 84 Australia Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 85 Australia Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 86 Thailand Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 87 Thailand Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 88 Thailand Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 89 Thailand Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 90 Latin America Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 91 Latin America Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 92 Latin America Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 93 Latin America Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 94 Latin America Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD million)
  • Table 95 Brazil Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 96 Brazil Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 97 Brazil Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 98 Brazil Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 99 Argentina Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 100 Argentina Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 101 Argentina Plasmid DNA Manufacturing Market by Applicationr, 2018 - 2030 (USD million)
  • Table 102 Argentina Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 103 Middle East & Africa Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 104 Middle East & Africa Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 105 Middle East & Africa Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 106 Middle East & Africa Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 107 Middle East & Africa Plasmid DNA Manufacturing Market by Country, 2018 - 2030 (USD million)
  • Table 108 South Africa Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 109 South Africa Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 110 South Africa Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 111 South Africa Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 112 Saudi Arabia Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 113 Saudi Arabia Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 114 Saudi Arabia Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 115 Saudi Arabia Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 116 UAE Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 117 UAE Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 118 UAE Plasmid DNA Manufacturing Market by Application, 2018 - 2030 (USD million)
  • Table 119 UAE Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 120 Kuwait Plasmid DNA Manufacturing Market by Grade, 2018 - 2030 (USD million)
  • Table 121 Kuwait Plasmid DNA Manufacturing Market by Development Phase, 2018 - 2030 (USD million)
  • Table 122 Kuwait Plasmid DNA Manufacturing Market By Application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Plasmid DNA Manufacturing Market by Disease, 2018 - 2030 (USD million)
  • Table 124 Participant's Overview
  • Table 125 Financial Performance
  • Table 126 Key Companies Undergoing Expansions
  • Table 127 Key Companies Undergoing Acquisitions
  • Table 128 Key Companies Undergoing Collaborations
  • Table 129 Key Companies Launching New Products/Services
  • Table 130 Key Companies Undergoing Partnerships
  • Table 131 Key Companies Undertaking Other Strategies

List of Figures

  • Figure 1. Global plasmid DNA manufacturing market segmentation
  • Figure 2. Market research process
  • Figure 3. Data triangulation techniques
  • Figure 4. Primary research pattern
  • Figure 5. Market research approaches
  • Figure 6. Market formulation & validation
  • Figure 7. Market outlook
  • Figure 8. Segment snapshot
  • Figure 9. Competitive landscape snapshot
  • Figure 10. Parent market outlook
  • Figure 11. Global plasmid DNA manufacturing market driver analysis
  • Figure 12. Global plasmid DNA manufacturing market restraint analysis
  • Figure 13. Global plasmid DNA manufacturing market: Porter's analysis
  • Figure 14. Global plasmid DNA manufacturing market: PESTEL analysis
  • Figure 15. Global plasmid DNA manufacturing market: Grade outlook and key takeaways
  • Figure 16. Global plasmid DNA manufacturing market: Grade movement analysis
  • Figure 17. Global R&D grade market, 2018 - 2030 (USD million)
  • Figure 18. Global viral vector development market, 2018 - 2030 (USD million)
  • Figure 19. Global mRNA development market, 2018 - 2030 (USD million)
  • Figure 20. Global antibody development market, 2018 - 2030 (USD million)
  • Figure 21. Global DNA vaccine development market, 2018 - 2030 (USD million)
  • Figure 22. Global others market, 2018 - 2030 (USD million)
  • Figure 23. Global AAV market, 2018 - 2030 (USD million)
  • Figure 24. Global lentivirus market, 2018 - 2030 (USD million)
  • Figure 25. Global adenovirus market, 2018 - 2030 (USD million)
  • Figure 26. Global retrovirus market, 2018 - 2030 (USD million)
  • Figure 27. Global GMP grade market, 2018 - 2030 (USD million)
  • Figure 28. Global others market, 2018 - 2030 (USD million)
  • Figure 29. Global plasmid DNA manufacturing market: Development phase outlook and key takeaways
  • Figure 30. Global plasmid DNA manufacturing market: Development phase movement analysis
  • Figure 31. Global pre-clinical therapeutics market, 2018 - 2030 (USD million)
  • Figure 32. Global clinical therapeutics market, 2018 - 2030 (USD million)
  • Figure 33. Global marketed therapeutics market, 2018 - 2030 (USD million)
  • Figure 34. Global plasmid DNA manufacturing market: Application outlook and key takeaways
  • Figure 35. Global plasmid DNA manufacturing market: Application movement analysis
  • Figure 36. Global DNA vaccines market, 2018 - 2030 (USD million)
  • Figure 37. Global cell & gene therapy market, 2018 - 2030 (USD million)
  • Figure 38. Global immunotherapy market, 2018 - 2030 (USD million)
  • Figure 39. Global others market, 2018 - 2030 (USD million)
  • Figure 40. Global plasmid DNA manufacturing market: Disease outlook and key takeaways
  • Figure 41. Global plasmid DNA manufacturing market: Disease movement analysis
  • Figure 42. Global infectious disease market, 2018 - 2030 (USD million)
  • Figure 43. Global cancer market, 2018 - 2030 (USD million)
  • Figure 44. Global genetic disorder market, 2018 - 2030 (USD million)
  • Figure 45. Global Others market, 2018 - 2030 (USD million)
  • Figure 46. Global plasmid DNA manufacturing market: Regional outlook and key takeaways
  • Figure 47. North America plasmid DNA manufacturing market, 2018 - 2030 (USD million)
  • Figure 48. U.S. key country dynamics
  • Figure 49. U.S. plasmid DNA manufacturing market, 2018 - 2030 (USD million)
  • Figure 50. Canada key country dynamics
  • Figure 51. Canada plasmid DNA manufacturing market, 2018 - 2030 (USD million)
  • Figure 52. Mexico key country dynamics
  • Figure 53. Mexico plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 54. Europe plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 55. Germany key country dynamics
  • Figure 56. Germany plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 57. France key country dynamics
  • Figure 58. France plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 59. U.K. key country dynamics
  • Figure 60. U.K. plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 61. Italy key country dynamics
  • Figure 62. Italy plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 63. Spain key country dynamics
  • Figure 64. Spain plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 65. Denmark key country dynamics
  • Figure 66. Denmark plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 67. Sweden key country dynamics
  • Figure 68. Sweden plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 69. Norway key country dynamics
  • Figure 70. Norway plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 71. Asia-Pacific plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 72. China key country dynamics
  • Figure 73. China plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 74. India key country dynamics
  • Figure 75. India plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 76. South Korea key country dynamics
  • Figure 77. South Korea plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 78. Japan key country dynamics
  • Figure 79. Japan plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 80. Australia key country dynamics
  • Figure 81. Australia plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 82. Thailand key country dynamics
  • Figure 83. Thailand plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 84. Latin America plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 85. Brazil key country dynamics
  • Figure 86. Brazil plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 87. Argentina key country dynamics
  • Figure 88. Argentina plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 89. MEA plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 90. South Africa key country dynamics
  • Figure 91. South Africa plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 92. Saudi Arabia key country dynamics
  • Figure 93. Saudi Arabia plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 94. UAE key country dynamics
  • Figure 95. UAE plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 96. Kuwait key country dynamics
  • Figure 97. Kuwait plasmid DNA manufacturing market estimates and forecast, 2018 - 2030 (USD million)
  • Figure 98. Market participant categorization
  • Figure 99. Plasmid DNA manufacturing market share analysis, 2023
  • Figure 100. Strategy framework